25/12/2013
NRC Okays U.S. Isotope Plant Construction Application
SHINE Medical Technologies, a Wisconsin-based producer of medical isotope technologies, announced Dec. 3 that the U.S. Nuclear Regulatory Committee (NRC) has accepted the second and final portion of the company's application for a construction permit to build an accelerator plant for medical isotopes including molybdenum-99, which would in turn create a U.S. supply of technetium-99.
For more information visit www.molecularimaging.net